Viewing StudyNCT01729663



Ignite Creation Date: 2024-05-06 @ 1:05 AM
Last Modification Date: 2024-10-26 @ 10:59 AM
Study NCT ID: NCT01729663
Status: UNKNOWN
Last Update Posted: 2015-09-02
First Post: 2012-11-14

Brief Title: Phase IIIII Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB IIC and III Melanoma Patients
Sponsor: Laboratorio Pablo Cassará SRL
Organization: Laboratorio Pablo Cassará SRL

Organization Data

Organization: Laboratorio Pablo Cassará SRL
Class: INDUSTRY
Study ID: CASVAC0401
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Laboratorio Pablo Cassará SRL
Lead Sponsor Class: INDUSTRY
Responsible Party: José Mordoh
Responsible Party Title: MD PhD
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Laboratorio Pablo Cassará SRL
Old Name: None
Old Organization: None

Collaborators

Name Class
Instituto Nacional del Cáncer Argentina OTHER_GOV
Fundacion Sales UNKNOWN
National Agency for Scientific and Technological Promotion Argentina OTHER
Fundacion Cancer FUCA UNKNOWN
National Council of Scientific and Technical Research Argentina OTHER_GOV